Innospace's Historic Launch for South Korea's First Commercial Rocket Delayed by Weather
South Korean startup Innospace's first commercial rocket launch, Hanbit-Nano, has been delayed in Brazil due to bad weather. A successful launch would be a historic first for the country's private space sector.
South Korean space startup Innospace Co. confirmed on Monday that the launch of its Hanbit-Nano rocket, the nation's first-ever commercial orbital vehicle, has been pushed back due to unfavorable weather at its launch site in Brazil.
Rain Halts Countdown at Alcantara
The rocket was originally scheduled to lift off from the Alcantara Space Center at 3:45 p.m. local time, according to the company. However, with rain forecast for the afternoon, operators delayed the attempt until after 10 p.m. The company explained that once the rain stops, the rocket needs to be erected, a process that requires at least six hours of preparation before the final countdown can begin.
"It is difficult to forecast the exact time the rain will stop," Innospace said in a statement. "We will monitor weather conditions and announce the launch time later." This marks the third postponement since the original launch date of November 22.
High Stakes for a New Space Player
A successful mission would make Innospace the first private South Korean company to place a customer satellite into orbit, a significant milestone for the country's burgeoning space industry. The Hanbit-Nano is carrying a payload of five satellites intended for deployment into a 300-kilometer low orbit.
The two-stage vehicle is powered by a 25-ton thrust hybrid engine in its first stage, while the second stage employs a liquid methane and oxygen engine. Now, this advanced hardware is waiting on one of technology's oldest adversaries: the weather.
本内容由AI根据原文进行摘要和分析。我们力求准确,但可能存在错误,建议核实原文。
相关文章
韓國太空新創公司Innospace的首枚商業火箭「Hanbit-Nano」因巴西發射場天氣惡劣而延後發射。本文深入解析其任務目標、技術規格及對韓國民間航太產業的重大意義。
南韓太空新創 Innospace 在三度延期後,計畫於本週發射首枚商業軌道火箭「韓光-奈米號」。若任務成功,將創下南韓民營太空史新頁。本文深入解析其技術細節與面臨挑戰。
美國FDA批准諾和諾德旗下減重藥物Wegovy的口服版本,為市場首例。新劑型提供與注射劑相當的療效,但便利性大增,預計2026年初於美國上市。
美國聯邦通信委員會(FCC)以國家安全風險為由,禁止新款外國製造無人機的進口。此舉對DJI等全球大廠造成衝擊,並預示著全球科技供應鏈的進一步重組。